RivoceranibVarious toxicities

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2000卷 / 1期

关键词：

D O I：

10.1007/s40278-024-55009-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：320 / 320

相关论文

共 50 条

[21] Capecitabine/gemcitabine/rivoceranibVarious toxicities: case report
Reactions Weekly, 2019, 1737 (1) : 75 - 75
[22] Camrelizumab/rivoceranibVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1939 (1) : 126 - 126
[23] Irinotecan/paclitaxel/rivoceranibVarious toxicities: case report
Reactions Weekly, 2021, 1875 (1) : 180 - 180
[24] Icotinib/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1705 (1) : 156 - 156
[25] Carboplatin/etoposide/rivoceranibVarious toxicities: case report
Reactions Weekly, 2018, 1717 (1) : 80 - 80
[26] Camrelizumab/rivoceranibVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1811 (1) : 79 - 79
[27] Camrelizumab/rivoceranibVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1925 (1) : 145 - 145
[28] RivoceranibVarious toxicities and development of resistance: case report
Reactions Weekly, 2019, 1737 (1) : 258 - 258
[29] Osimertinib/rivoceranibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1871 (1) : 336 - 336
[30] Gimeracil/oteracil/tegafur/rivoceranibVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1844 (1) : 197 - 197

← 1 2 3 4 5 →